DDIT3 and plasma cell myeloma: Thus, our results confirm those of Lengwehasatit and Dickson with the NS0 myeloma [13] and Murphy et al. in CHO cells [14] that Gadd153 expression is responsive to nutrient supplementation in a cell line of biotechnological interest.